Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Temsirolimus
Cat. No.:
OB0225LY-0332
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Temsirolimus is an inhibitor that targets mTOR and has important effects on cell proliferation and survival.
Synonym:
NSC 683864; CCI-779; 162635-04-3; Torisel; Rapamycin 42-(2,2-bis(hydroxymethyl)propionate); 42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin
CAS No.:
162635-04-3
Compound CID:
6918289
Formula:
C56H87NO16
Formula Weight:
1030.29
Specification
Relative Density:
1.2 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Temsirolimus can be used in cancer research or play an important role in cell signaling studies.
Library Information
Targets:
PI3K/Akt/mTOR pathway
Receptors:
mTOR
Pathways:
Apoptosis; PI3K/Akt/mTOR signaling; Autophagy
Plate Number:
AOCL-5
Plate Location:
c6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
70 mg/mL; 67.9 mM
ALogP:
6.039
HBA_Count:
12
HBD_Count:
3
Rotatable Bond:
11
